Literature DB >> 26823912

Aberrant promoter methylation of SH3GL2 gene in vulvar squamous cell carcinoma correlates with clinicopathological characteristics and HPV infection status.

Bo Li1, Yinghui He1, Xue Han1, Shitai Zhang1, Yan Xu1, Yang Zhou1, Zixuan Song1, Ling Ouyang1.   

Abstract

OBJECTIVE: This study attempted to examine the methylation status of SH3GL2 gene in different types of human vulvar lesions and its correlation with clinicopathological parameters.
METHODS: Immunohistochemical analysis was used to identify the expression status of SH3GL2 in vulvar squamous cell carcinoma (VSCC), vulvar intraepithelial neoplasia (VIN) and benign vulvar squamous epithelium tissues. Bisulfite genomic sequencing method was used to detect methylation status of the SH3GL2 gene. Clinicopathological correlation of the alterations was analysed by the chi-square tests.
RESULTS: Immunohistochemical analysis showed expression of SH3GL2 in VSCC was significantly downregulated than that in VIN and normal vulvar tissues. In accordance with higher frequency of methylation status in SH3GL2, statistical analysis showed methylation status of SH3GL2 was closely related to tumor TNM stage (P=0.003), but not related to age, tumor volume, tumor differentiation, lymph node metastasis and VIN grade. High-methylation status of SH3GL2 showed significant association with HPV infection status.
CONCLUSIONS: Our results indicated that the methylation status of SH3GL2 gene was associated with the TNM staging and HPV infection status of VSCC, suggesting that it might play a synergistic role in the development of VSCC.

Entities:  

Keywords:  SH3GL2; methylation; vulvar squamous cell carcinoma

Mesh:

Substances:

Year:  2015        PMID: 26823912      PMCID: PMC4713698     

Source DB:  PubMed          Journal:  Int J Clin Exp Pathol        ISSN: 1936-2625


  13 in total

Review 1.  Review of the current knowledge on the epidemiology, pathogenesis, and prevention of human papillomavirus infection.

Authors:  Asia Asiaf; Shiekh T Ahmad; Sheikh O Mohammad; Mohammad A Zargar
Journal:  Eur J Cancer Prev       Date:  2014-05       Impact factor: 2.497

2.  Cloning of ligand targets: systematic isolation of SH3 domain-containing proteins.

Authors:  A B Sparks; N G Hoffman; S J McConnell; D M Fowlkes; B K Kay
Journal:  Nat Biotechnol       Date:  1996-06       Impact factor: 54.908

3.  Study of the SH3-domain GRB2-like 2 gene expression in laryngeal carcinoma.

Authors:  Chao Shang; Wei-neng Fu; Yan Guo; Dai-fa Huang; Kai-lai Sun
Journal:  Chin Med J (Engl)       Date:  2007-03-05       Impact factor: 2.628

4.  The SH3p4/Sh3p8/SH3p13 protein family: binding partners for synaptojanin and dynamin via a Grb2-like Src homology 3 domain.

Authors:  N Ringstad; Y Nemoto; P De Camilli
Journal:  Proc Natl Acad Sci U S A       Date:  1997-08-05       Impact factor: 11.205

Review 5.  CpG island hypermethylation as a biomarker for the early detection of lung cancer.

Authors:  Yujin Kim; Duk-Hwan Kim
Journal:  Methods Mol Biol       Date:  2015

6.  Frequent deletion and methylation in SH3GL2 and CDKN2A loci are associated with early- and late-onset breast carcinoma.

Authors:  Satyabrata Sinha; Neelanjana Chunder; Nupur Mukherjee; Neyaz Alam; Anup Roy; Susanta Roychoudhury; Chinmay Kumar Panda
Journal:  Ann Surg Oncol       Date:  2008-02-01       Impact factor: 5.344

7.  [Chromosomal aberration in vulvar squamous cell carcinoma analyzed by comparative genomic hybridization].

Authors:  Ling Ouyang; Shu-Lan Zhang; Rong-Li Chen; Bo Li; Li-Li Chen
Journal:  Ai Zheng       Date:  2007-06

8.  Loss of Sh3gl2/endophilin A1 is a common event in urothelial carcinoma that promotes malignant behavior.

Authors:  Shyama Majumdar; Edward M Gong; Dolores Di Vizio; Jonathan Dreyfuss; David J Degraff; Martin H Hager; Peter J Park; Joaquim Bellmunt; Robert J Matusik; Jonathan E Rosenberg; Rosalyn M Adam
Journal:  Neoplasia       Date:  2013-07       Impact factor: 5.715

Review 9.  Vulvar cancer: epidemiology, clinical presentation, and management options.

Authors:  Ibrahim Alkatout; Melanie Schubert; Nele Garbrecht; Marion Tina Weigel; Walter Jonat; Christoph Mundhenke; Veronika Günther
Journal:  Int J Womens Health       Date:  2015-03-20

10.  Potential predictive markers of chemotherapy resistance in stage III ovarian serous carcinomas.

Authors:  Lovisa Osterberg; Kristina Levan; Karolina Partheen; Ulla Delle; Björn Olsson; Karin Sundfeldt; György Horvath
Journal:  BMC Cancer       Date:  2009-10-18       Impact factor: 4.430

View more
  2 in total

Review 1.  Molecular events in the pathogenesis of vulvar squamous cell carcinoma.

Authors:  Deyin Xing; Oluwole Fadare
Journal:  Semin Diagn Pathol       Date:  2020-09-25       Impact factor: 3.464

2.  DNA methylation markers for cancer risk prediction of vulvar intraepithelial neoplasia.

Authors:  Nikki B Thuijs; Johannes Berkhof; Müjde Özer; Sylvia Duin; Annina P van Splunter; Barbara C Snoek; Daniëlle A M Heideman; Marc van Beurden; Renske D M Steenbergen; Maaike C G Bleeker
Journal:  Int J Cancer       Date:  2021-01-10       Impact factor: 7.396

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.